• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Other Chemical additives

Comprehensive Guide to Tert-Butyl 12-hydroxy-4,7,10-trioxadodecanoate (CAS No. 186020-66-6): Properties, Applications, and Industry Insights

Tert-Butyl 12-hydroxy-4,7,10-trioxadodecanoate (CAS No. 186020-66-6) is a specialized polyether ester compound gaining attention in pharmaceutical intermediates, polymer science, and specialty chemical synthesis. This hydroxyl-functionalized derivative features a unique trioxadodecanoate backbone, making it valuable for controlled-release formulations and biocompatible material design. With the rise of green chemistry and sustainable synthesis trends, researchers are increasingly exploring its role as a PEG-like building block for drug delivery systems.

The compound’s tert-butyl ester group provides enhanced stability during synthetic processes, while the 12-hydroxy moiety offers a reactive site for further modifications. Recent studies highlight its utility in creating water-soluble prodrugs, addressing common challenges like bioavailability enhancement – a hot topic in pharmacokinetic optimization discussions. Analytical data shows exceptional purity (>98%) by HPLC, meeting stringent requirements for GMP-grade applications.

In material science, CAS 186020-66-6 serves as a key monomer for biodegradable polymers, aligning with the global push toward eco-friendly plastics. Its ether-oxygen rich structure enables tunable hydrophilicity, answering industry demands for customizable solubility profiles. Patent literature reveals innovative uses in medical device coatings, where its low cytotoxicity proves advantageous for implantable technologies – a rapidly growing sector projected to reach $140 billion by 2028.

Quality control protocols for Tert-Butyl 12-hydroxy-4,7,10-trioxadodecanoate emphasize residual solvent monitoring and endotoxin testing, particularly for parenteral-grade applications. Storage recommendations typically specify argon-protected conditions at -20°C to preserve the hydroxyl group reactivity. These handling precautions reflect broader industry concerns about compound degradation during logistics – a frequent search query among process chemists.

Emerging research explores the compound’s potential in RNA therapeutics, leveraging its PEGylation-like properties to improve oligonucleotide stability. This application taps into the booming mRNA technology market, where delivery system optimization remains a critical challenge. Comparative studies suggest superior metabolic stability versus traditional PEG linkers, making CAS 186020-66-6 a promising candidate for next-generation vaccine adjuvants.

Regulatory status varies by region, but most jurisdictions classify the compound as non-hazardous under standard handling conditions. Safety data sheets recommend standard laboratory precautions, with particular attention to moisture-sensitive storage. These characteristics position it favorably against alternative hydrophilic linkers that often require specialized containment – a significant advantage in scale-up manufacturing scenarios.

Synthetic routes to Tert-Butyl 12-hydroxy-4,7,10-trioxadodecanoate typically involve multi-step etherification followed by selective esterification. Recent process improvements have achieved atom economy exceeding 85%, responding to pharmaceutical industry demands for cost-effective intermediates. Analytical characterization employs advanced techniques like 2D NMR and high-resolution mass spectrometry to verify the regiochemical purity – a critical quality attribute for chiral synthesis applications.

The compound’s structure-activity relationships are being actively investigated for targeted drug delivery systems. Its balanced lipophilicity (LogP ~0.9) enables efficient membrane penetration while maintaining aqueous solubility – properties highly sought after in CNS drug development. These characteristics explain growing interest from blood-brain barrier research teams worldwide.

Market analysts note increasing procurement of CAS 186020-66-6 by CDMO facilities, particularly for ADC (antibody-drug conjugate) platforms. The compound’s spacer arm functionality allows precise control over drug-loading ratios, addressing a key pain point in bioconjugation chemistry. Supplier databases indicate 30% year-over-year growth in technical inquiries, reflecting expanding applications in precision medicine pipelines.

Environmental fate studies demonstrate ready biodegradability of the trioxadodecanoate chain, an important consideration for green chemistry certifications. Lifecycle assessments compare favorably against conventional petroleum-derived linkers, supporting claims of sustainable chemistry – a major selling point for ESG-conscious manufacturers. These attributes contribute to its inclusion in several bio-preferred product lists.

Future developments may explore enzyme-triggered release systems utilizing the compound’s esterase sensitivity. Preliminary data suggests programmable hydrolysis kinetics in physiological conditions, potentially enabling site-specific activation of therapeutic payloads. Such innovations could revolutionize smart drug delivery – currently one of the most searched topics in pharmaceutical R&D circles.

• 883554-11-8(m-PEG4-Boc)
• 778596-26-2(HO-PEG10-tBu)
• 892154-71-1(HO-PEG12-CH2CH2COOtBu)
• 1186025-29-5(Ho-peg(24)-co-tbu)
• 671802-00-9(Tert-butyl 3-(2-hydroxyethoxy)propanoate)
• 518044-32-1(Tert-butyl 1-hydroxy-3,6,9,12-tetraoxapentadecan-15-oate)
• 1334177-84-2(Hydroxy-PEG8-t-butyl ester)
• 361189-64-2(Hydroxy-PEG6-t-butyl ester)
• 133803-81-3(Tert-Butyl 3-(2-(2-hydroxyethoxy)ethoxy)propanoate)
• 850090-09-4(Hydroxy-PEG-5-t-butyl ester)